ReviewJournal of personalized medicine2022
Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma.
Serafeim Chrysovalantis Kotoulas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it